Expert Pitch

Renewables take a blow from coronavirus, but recovery expected

Cornell University
31-Mar-2020 11:50 AM EDT, by Cornell University

Wind, solar and battery industries have suffered with the spread of the coronavirus and reports from industry leaders forecast cutbacks and erasing of growth.

John Tobin is professor of practice at the SC Johnson College of Business at Cornell University, an expert on environmental and energy economics and a faculty fellow at the Cornell Atkinson Center for Sustainability. He says that the pandemic, combined with falling oil prices, is detrimental to renewables in the short term, but that the sector will recover with the help of long-term growth in market demand.

Bio: https://dyson.cornell.edu/faculty-research/faculty/jt728/

Tobin says:

“In the short term, investments in alternative energy are likely to be strongly impacted by the COVID-19 pandemic and the ongoing oil price war between two of the biggest oil producers in the world. The impact of the pandemic on the real economy is going to be severe, at least in the short term, and will put a damper on capital expenditures throughout the economy, including on solar, wind, and battery power.

“Add to this the fact that the 2016 oil production agreement between Russia and Saudi Arabia seems to have fallen apart and the price of oil is now lower than it has been for nearly 20 years means that the price incentive to switch to alternative power is not quite there.

“However, the economy will recover and the price of oil will climb back up to more realistic levels—and the growth of alternative energy is part of a secular trend resulting from growing market demand, pressure from policymakers, and a recognition of the negative impacts of fossil fuels. The medium- and long-term outlook of the alternative energy sector does not look materially different at this point compared to before the COVID-19 pandemic.”

Please find other experts at Cornell available to discuss the coronavirus crisis from a science  and public health perspectivefor its impact on the economy and in the ways the pandemic is changing our daily lives.

- 30 -



Filters close

Showing results

1120 of 5809
Released: 10-Jun-2021 4:05 PM EDT
Study Identifies How COVID-19 Linked to Alzheimer’s Disease-like Cognitive Impairment
Cleveland Clinic

A new Cleveland Clinic-led study has identified mechanisms by which COVID-19 can lead to Alzheimer’s disease-like dementia. The findings, published in Alzheimer's Research & Therapy, indicate an overlap between COVID-19 and brain changes common in Alzheimer’s, and may help inform risk management and therapeutic strategies for COVID-19-associated cognitive impairment.

Released: 10-Jun-2021 3:25 PM EDT
5 Leadership Strategies for Better Adapting in a Crisis
University of Maryland, Robert H. Smith School of Business

Maryland Smith management expert and futurist Oliver Schlake describes how companies can prepare for the next crisis as the economy gradually emerges from the COVID-19 pandemic.

7-Jun-2021 2:30 PM EDT
COVID-19 Creates Hearing, Balance Disorders, Aggravates Tinnitus Symptoms
Acoustical Society of America (ASA)

Evidence suggests auditory and vestibular effects should be added to the growing list of physiological impacts of COVID-19. During the 180th Meeting, Colleen Le Prell from the University of Texas at Dallas will talk about hearing and balance disorders associated with coronavirus infection and how pandemic-related stress and anxiety may aggravate tinnitus symptoms. Her presentation, "Hearing disorders secondary to infection with SARS-CoV-2," will take place Thursday, June 10.

Released: 10-Jun-2021 10:55 AM EDT
NCCN Cancer Experts Answer Questions about COVID-19 Vaccines
National Comprehensive Cancer Network® (NCCN®)

National Comprehensive Cancer Network’s patient information team provides a patient and caregiver version of recently-updated, evidence-based expert consensus recommendations for vaccinating people with cancer against COVID-19.

Newswise:Video Embedded doe-scientists-deploy-creativity-speed-to-disrupt-covid-19
VIDEO
Released: 10-Jun-2021 9:00 AM EDT
DOE scientists deploy creativity, speed to disrupt COVID-19
Oak Ridge National Laboratory

An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.

Released: 10-Jun-2021 9:00 AM EDT
Warmer temperatures lessen COVID-19 spread, but control measures still needed
Imperial College London

New research shows transmission of the virus behind COVID-19 varies seasonally, but warmer conditions are not enough to prevent transmission.

8-Jun-2021 12:45 PM EDT
Monoclonal antibody therapy for COVID-19 safe, effective for transplant patients
Mayo Clinic

Treating transplant patients with mild to moderate cases of COVID-19 with monoclonal antibodies is safe and helps prevent serious illness, according to a Mayo Clinic study recently published in Open Forum Infectious Diseases. These results are especially important because transplant patients who are infected with COVID-19 have a higher risk of severe illness and death.

4-Jun-2021 2:25 PM EDT
Study Examines COVID-19 Among Patients Receiving Home Dialysis
American Society of Nephrology (ASN)

• Patients with kidney failure who are undergoing dialysis—whether at dialysis clinics or at home—face a higher risk of developing COVID-19 and a higher risk of dying from the disease.

4-Jun-2021 2:30 PM EDT
Immune Responses After COVID-19 Vaccination in Kidney Transplant Recipients and Patients on Dialysis
American Society of Nephrology (ASN)

• A large majority of patients with kidney failure on dialysis—but not kidney transplant recipients—developed antibody responses to SARS-CoV-2 after COVID-19 vaccination. • Vaccination also led to strong T cell responses against the virus that causes COVID-19 in all patients on dialysis, and in nearly 58% of kidney transplant recipients.

Newswise: New treatment demonstrated for people with vaccine clots
8-Jun-2021 10:50 AM EDT
New treatment demonstrated for people with vaccine clots
McMaster University

The treatment’s effectiveness was described in a report describing three Canadian patients who received the AstraZeneca vaccine, and who subsequently developed VITT. Two suffered clotting in their legs and the third had clots blocking arteries and veins inside their brain.


Showing results

1120 of 5809

close
1.94844